The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Ikonics Corp

Nasdaq: IKNX
Last

(U.S.) $8.31

Today's change-0.19 -2.26%
Updated June 23 3:38 PM -4GMT. Delayed by at least 15 minutes.
 

Ikonics Corp

Nasdaq: IKNX
Last

(U.S.) $8.31

Today's change-0.19 -2.26%
Updated June 23 3:38 PM -4GMT. Delayed by at least 15 minutes.

Sharp drop following new 20-day high

Ikonics Corp closed sharply lower Friday, dropping (U.S.)$0.19 or 2.26% to (U.S.)$8.31 after setting a new 20-day high. Over the last five days, shares have gained 2.32%, but are down 26.15% for the last year to date. Shares have underperformed the S&P 500 by 37.00% during the last year.

Key company metrics

  • Open(U.S.) $8.86
  • Previous close(U.S.) $8.50
  • High(U.S.) $9.26
  • Low(U.S.) $8.28
  • Bid / Ask-- / --
  • YTD % change-26.15%
  • Volume6,593
  • Average volume (10-day)3,636
  • Average volume (1-month)4,366
  • Average volume (3-month)2,342
  • 52-week range(U.S.) $7.40 to (U.S.) $13.95
  • Beta0.33
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.12
Updated June 23 3:38 PM -4GMT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-1.46%

Ikonics Corp has a net profit margin of -1.46%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.65%Sector:Basic MaterialsIndustry:Chemicals - Specialty

Latest Company News

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue4554
Total other revenue--------
Total revenue4554
Gross profit1222
Total cost of revenue3333
Total operating expense4544
Selling / general / administrative2111
Research & development0000
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-1000
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax-1000
Income after tax0000
Income tax, total0000
Net income0000
Total adjustments to net income--------
Net income before extra. items0000
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items0000
Inc. avail. to common incl. extra. items0000
Diluted net income0000
Dilution adjustment--------
Diluted weighted average shares2222
Diluted EPS excluding extraordinary itemsvalue per share-0.190.000.040.02
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share-0.190.000.040.02